Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-003034
Filing Date
2024-02-08
Accepted
2024-02-08 17:05:48
Documents
2
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 form3-02082024_100241.html 3  
1 form3-02082024_100241.xml 3 1763
2 ex24-02082024_100241.htm EX-24 3480
  Complete submission text file 0001415889-24-003034.txt   6720
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ADAMAS PHARMACEUTICALS INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address
Rhodes Jennifer J (Reporting) CIK: 0001568249 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50768 | Film No.: 24610043